Intellia Therapeutics Investors Urged to Seek Counsel Before Crucial Deadline in Securities Lawsuit

Sunday 16th of March 2025 16:09:00

ROSEN A HIGHLY RECOGNIZED LAW FIRM ENCOURAGES INTELLIA THERAPEUTICS INC INVESTORS TO SECURE COUNSEL BEFORE DEADLINE IN CLASS ACTION LAWSUIT

New York, New York – Rosen Law Firm, a highly recognized law firm, reminds investors that they have until [DEADLINE] to file a lead plaintiff motion in the securities class action lawsuit against Intellia Therapeutics, Inc. (NASDAQ: NTLA).

On March 15, 2023, the United States District Court for the Southern District of New York issued an order appointing Rosen Law Firm as lead counsel in the securities class action lawsuit captioned "Klein v. Intellia Therapeutics, Inc., et al., Case No. 1:23-cv-00342."

The lawsuit alleges that Intellia Therapeutics, Inc. and certain of its officers and directors made false and/or misleading statements and/or failed to disclose material information during the period of [DATE] to [DATE]. The lawsuit seeks to recover damages for Intellia Therapeutics, Inc. investors who purchased the Company's securities during the class period.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose material information during the class period, causing Intellia Therapeutics, Inc. investors to suffer significant losses.

Rosen Law Firm encourages investors who purchased Intellia Therapeutics, Inc. securities during the class period to contact the firm to secure counsel and potentially recover damages.

If you have purchased Intellia Therapeutics, Inc. securities during the class period and would like to join the lawsuit or discuss your rights or recoveries, please contact Laurence Rosen, Esq. of Rosen Law Firm, toll-free, at 866-767-3683 or via e-mail at lrosen@rosenlegal.com. A copy of the complaint can be obtained by visiting the firm's website at www.rosenlegal.com.

Rosen Law Firm represents investors worldwide, focusing exclusively on securities law litigation. The firm has secured hundreds of millions of dollars for investors in securities cases.